181 related articles for article (PubMed ID: 35589630)
21. [Neurosarcoidosis].
Reith W; Roumia S; Popp C
Radiologe; 2016 Oct; 56(10):898-903. PubMed ID: 27638827
[TBL] [Abstract][Full Text] [Related]
22. Neurosarcoidosis: report of 30 cases and a literature survey.
Gascón-Bayarri J; Mañá J; Martínez-Yélamos S; Murillo O; Reñé R; Rubio F
Eur J Intern Med; 2011 Dec; 22(6):e125-32. PubMed ID: 22075297
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide for acute treatment of neurosarcoidosis.
Hammond ER; Kaplin AI; Kerr DA
Spinal Cord; 2007 Dec; 45(12):802-3. PubMed ID: 17710103
[TBL] [Abstract][Full Text] [Related]
24. [Neurosarcoidosis: Diagnosis and therapeutic issues].
Cohen Aubart F; Galanaud D; Haroche J; Psimaras D; Mathian A; Hié M; Le-Thi Huong Boutin D; Charlotte F; Maillart E; Maisonobe T; Amoura Z
Rev Med Interne; 2017 Jun; 38(6):393-401. PubMed ID: 27884456
[TBL] [Abstract][Full Text] [Related]
25. A pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century.
Hoitsma E; Drent M; Sharma OP
Curr Opin Pulm Med; 2010 Sep; 16(5):472-9. PubMed ID: 20671516
[TBL] [Abstract][Full Text] [Related]
26. Nonsteroidal therapy of sarcoidosis.
Korsten P; Mirsaeidi M; Sweiss NJ
Curr Opin Pulm Med; 2013 Sep; 19(5):516-23. PubMed ID: 23884295
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
[TBL] [Abstract][Full Text] [Related]
28. Reply: Treatment of refractory neurosarcoidosis with tumour necrosis factor inhibitors--what lies ahead?
Pereira JA; Anderson NE
Intern Med J; 2012 Apr; 42(4):478-9. PubMed ID: 22498131
[No Abstract] [Full Text] [Related]
29. Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab.
Marnane M; Lynch T; Scott J; Stack J; Kelly PJ
J Neurol; 2009 Jan; 256(1):139-40. PubMed ID: 19219574
[No Abstract] [Full Text] [Related]
30. [Sarcoidosis in Central Nervous System].
Koga M
Brain Nerve; 2021 May; 73(5):576-583. PubMed ID: 34006691
[TBL] [Abstract][Full Text] [Related]
31. [Neurological involvement of sarcoidosis: current diagnostic and therapeutic strategies].
Desbois AC; Shor N; Chapelon C; Maillart E; Touitou V; Cacoub P; Saadoun D
Rev Med Interne; 2023 Mar; 44(3):123-132. PubMed ID: 36804049
[TBL] [Abstract][Full Text] [Related]
32. Adalimumab for CNS sarcoidosis: single-center experience and literature review.
Hutto SK; Kyle K; Cavanagh JJ; Reda H; Venna N
J Neurol; 2022 Apr; 269(4):2064-2072. PubMed ID: 34487233
[TBL] [Abstract][Full Text] [Related]
33. Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice.
Lorentzen AO; Sveberg L; Midtvedt Ø; Kerty E; Heuser K
Clin Neuropharmacol; 2014; 37(5):142-8. PubMed ID: 25229171
[TBL] [Abstract][Full Text] [Related]
34. Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment.
Gosselin J; Roy-Hewitson C; Bullis SSM; DeWitt JC; Soares BP; Dasari S; Nevares A
Curr Rheumatol Rep; 2022 Dec; 24(12):371-382. PubMed ID: 36223002
[TBL] [Abstract][Full Text] [Related]
35. [Central nervous system involvement of sarcoidosis: diagnosis and management].
Kumamoto T
Rinsho Shinkeigaku; 2012; 52(11):1237-9. PubMed ID: 23196575
[TBL] [Abstract][Full Text] [Related]
36. Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis.
Rao R; Dimitriades VR; Weimer M; Sandlin C
Pediatr Neurol; 2016 Oct; 63():45-52. PubMed ID: 27524272
[TBL] [Abstract][Full Text] [Related]
37. Isolated spinal cord neurosarcoidosis diagnosed by cord biopsy and thalidomide trial.
Ahn SW; Kim KT; Youn YC; Kwon OS; Kim YB
J Korean Med Sci; 2011 Jan; 26(1):154-7. PubMed ID: 21218047
[TBL] [Abstract][Full Text] [Related]
38. [Neurosarcoidosis - clinical characteristics, diagnosis and treatment].
Horyniecki M; Konieczna M; Torbus M; Pierzchała K; Wawrzyńczyk M; Łabuz-Roszak B
Wiad Lek; 2016; 69(1 Pt 2):92-8. PubMed ID: 27164284
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic agents in sarcoidosis: which one should we choose?
Vorselaars AD; Cremers JP; Grutters JC; Drent M
Curr Opin Pulm Med; 2014 Sep; 20(5):479-87. PubMed ID: 25046427
[TBL] [Abstract][Full Text] [Related]
40. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
Gelfand JM; Bradshaw MJ; Stern BJ; Clifford DB; Wang Y; Cho TA; Koth LL; Hauser SL; Dierkhising J; Vu N; Sriram S; Moses H; Bagnato F; Kaufmann JA; Ammah DJ; Yohannes TH; Hamblin MJ; Venna N; Green AJ; Pawate S
Neurology; 2017 Nov; 89(20):2092-2100. PubMed ID: 29030454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
